Albemarle (ALB) Receives a Hold from Wells Fargo

Wells Fargo analyst Michael Sison reiterated a Hold rating on Albemarle yesterday and set a price target of $165.00. The company’s shares closed yesterday at $172.35.

Easter Sale - 70% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Sison covers the Basic Materials sector, focusing on stocks such as Albemarle, Air Products and Chemicals, and Celanese. According to TipRanks, Sison has an average return of -1.4% and a 41.67% success rate on recommended stocks.

In addition to Wells Fargo, Albemarle also received a Hold from TipRanks – Anthropic’s Anthropic Chemicals – Specialty in a report issued on March 26. However, yesterday, UBS maintained a Buy rating on Albemarle (NYSE: ALB).

Based on Albemarle’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.43 billion and a GAAP net loss of $414.18 million. In comparison, last year the company earned a revenue of $1.23 billion and had a net profit of $75.29 million

Based on the recent corporate insider activity of 53 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ALB in relation to earlier this year. Most recently, in February 2026, Eric Norris, the CCO of ALB sold 5,692.00 shares for a total of $941,741.40.